Videos
Dana Goldman, PhD discusses the results of a Journal of the American Medical Association study analyzing the effects of cost increases in children's asthma medication.
Advertisement
Advertisement
Trending on Pharmacy Times
1
CMS Announces 15 Drugs for Third Cycle of Medicare Drug Price Negotiation Program
2
Centanafadine for Treatment of ADHD in Children, Adolescents, and Adults Accepted By FDA for Priority Review
3
Abortive Treatments for Acute Migraine: Lasmiditan and CGRP Receptor Antagonists
4
FDA Grants Orphan Drug Designation to Zavabresib for the Treatment of Myelofibrosis
5